Development of an epidemiological and molecular integrated approach for the prevention of congenital hypothyroidism
Year: 2010
Type: article
Abstract: Congenital Hypothyroidism (CH) is a multifactorial disease in which genetic and environmental risk factors contribute to its aetiology. It represents the most frequent endocrinopathy in infancy (1:2500 live borns in Italy) and the most common cause of preventable mental retardation. In fact, an early treatment with the replacement therapy (Lthyroxine) prevents severe neuropsychological sequelae due to thyroid deficit in the neonatal period. CH is considered a rare disease given a prevalence of 3.5 cases/10,000 citizens in Italy. By measuring thyroid hormone and Thyroid Stimulating Hormone (TSH) in all babies shortly after birth, newborn screening programs are able to identify biochemically infants who may have CH even before there are any signs or symptoms of hypothyroidism. The majority of babies with CH are characterized by dysgenesis of the thyroid (agenetic, ectopic or hypoplastic gland) while inherited defects of thyroid hormone biosynthesis, secretion and utilization represent a minor fraction of all cases. It has been also demonstrated a high risk of extrathyroidal congenital malformations associated with CH. As we previously demonstrated, this risk is particularly high for malformations concerning heart, neural tube, eye and multiple malformations. This suggests that a very precocious molecular defect may occur during embryo development to explain the association between CH and malformations in organs that, like the thyroid, represent precocious structures in the developing embryo.
Authors: Cerone, Roberto, De Felice, Mario, Di Lauro, Roberto, Medda, Emanuela, Persani, Luca, Taruscio, Domenica, Tonacchera, Massimo, Bianchi, Fabrizio, Minichilli, Fabrizio, Olivieri, Antonella
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7046494595
